2026 Cochrane Review Finds Limited Evidence for CBD in Neuropathic Pain Relief By CBDWorldNews Editorial Staff | May 19, 2026 LONDON — A 2026 Cochrane…
CBDWorldNews Editorial Staff | May 16, 2026 State Cannabis Regulator Steps Into Clinical Research New York’s Office of Cannabis Management (OCM) announced a pilot study…
CBDWorldNews Editorial Staff | May 16, 2026 Revenue Climbs but Losses Persist for Publicly Traded CBD Brand cbdMD, Inc. (AMEX: YCBD) reported second-quarter fiscal 2026…
CBDWorldNews Editorial Staff | May 16, 2026 House Vote Leaves $28 Billion Hemp Industry Without Lifeline The U.S. House of Representatives voted 224-200 on April…
White House Drug Strategy Declares Hemp-Derived THC Products Schedule I The 2026 National Drug Control Strategy treats delta-8, delta-10, THC-O, and similar hemp derivatives as…
cbdMD Posts 19% Revenue Jump After Bluebird Botanicals Acquisition The CBD company’s wholesale channel surged 65% year-over-year as the newly acquired Bluebird brand turned profitable…
Texas Supreme Court Lifts Injunction, Clears Path for Delta-8 THC Ban The ruling lets the Department of State Health Services enforce its Schedule I classification…